Introduction

Introduction

We are entering a new era of healthcare based on a categorically different kind of medicine whose purpose isn’t just to save us from illness, but to help us be the best version of ourselves.

Up until now, medicine has been about damage control. Whether it is aspirin for a headache, antibiotics for an infection, or chemotherapy for cancer, we reach for medicine when something has gone wrong. Even preventative medicines like vaccines for infectious disease and statins for heart disease are about avoiding disaster.

Today, the shift has finally begun in earnest toward a new medical paradigm that centers on optimization instead of illness.

RethinkX calls these new medicines health optimizer therapies, or HOTs.

The first new HOTs are blockbuster GLP-1 agonist drugs like semaglutide, better known by its brand names Ozempic and Wegovy. But Ozempic is just the beginning. The next generation of HOTs will trigger a multi-trillion-dollar global disruption, affecting dozens of industries across multiple sectors, driving a radical global improvement in health and wellness encompassing at least 1 billion people worldwide before 2040. The enormous impact of HOTs will reshape economies and societies in fundamental ways. These impacts will be especially pronounced for middle-aged and elderly adults, who will experience HOTs as a stunningly effective anti-aging and rejuvenation therapy.

HOTs will transform humanity’s relationship with medicine and require us to fundamentally rethink health and wellness.

For our ancient ancestors food was energy, and every calorie was precious. Like other animals, our instincts were shaped by evolution to find calorie-dense foods like sugars, starches, fats, and even alcohol delicious. We evolved to avoid expending energy wherever possible, which is why resisting food and doing exercise require so much effort and self-discipline – our primal instincts scream at us to snack and laze around instead.

Yet here in the 21st Century, calories are plentiful and sedentary lifestyles are viable, freeing us to indulge our natural impulses to overeat and be lazy. The very mechanisms our bodies evolved to protect us amidst ancient conditions of scarcity - namely storing calories and minimizing energy use to maintain muscle - are now counterproductive to our health and wellbeing, especially as we age.

We all know we should eat less and exercise more. But life is hard, and hundreds of millions of us worldwide have struggled unsuccessfully to be our best selves. Mustering the willpower to say no to food and yes to the gym is just too difficult.

That is all about to change.

The convergence of highly-effective glucagon-like peptide-1 receptor agonist drugs (GLP-1s) for fat loss, together with myostatin and activin blocking antibody drugs for muscle gain, is poised to offer something very close to one of the elusive ‘holy grails’ that medical science has pursued for generations: “diet and exercise in a bottle”.

And this particular health optimizer therapy is just the beginning.

Humanity has been through dramatic health transformations before. For millennia up through the 19th Century, the primary role of food in relation to health across all of the world’s societies was as a source of sustenance to fend off starvation. Only starting in the 20th Century did we collectively begin to understand the healthiness of food in terms of nutrition, thanks to advancements in science, technology, and economic prosperity.

Today, a healthy diet means far more than just a full belly – it means consuming the optimal amount of protein, carbohydrates, fats, vitamins, minerals, fiber, and so on. And, very importantly, we now have the option to supplement our food with specific nutrients according to our personal health needs.

What happened with nutrition in the 20th Century is now about to happen with medicine in the 21st Century.

Drugs will no longer just be blunt instruments we use to stave off disaster, but precision tools we use as continuous supplements to optimize and maintain our health according to our individual needs.

Optimizing well with advanced HOTs will soon become as important as eating well with nutritious foods.

Today's HOTs are just the beginning

Today's HOTs based on current-generation GLP-1 pharmaceuticals are the subject of this report, but they represent just one example of a wider constellation of Health Optimizer Therapies.

HOTs are a broad category of disruptive new medical technologies that will recenter medicine around the proactive pursuit of human flourishing.

By targeting the fundamental biological systems that govern energy, cognition, aging, and resilience, future HOTs will transform not just medicine but how we as individuals, institutions, and societies understand the fullness of human potential.

As their adoption accelerates and their implications ripple across every sector of the economy and society, HOTs will reshape our industries, our communities, and our lives.